Operating Margin: 19.94%
Is the operating margin high or low?
The operating margin of 19.94% is 49% above its 5-year average of 13.41%, near the high end of its 5-year range (-25.52%–21.97%).
As of Friday, June 26, 2026. 12.43% above its 12-month average of 17.74%.
STE Operating Margin
Reported quarterly operating margin; no daily interpolation.
STE Average Operating Margin Chart
STE Current vs Average Operating Margin Chart
STE Operating Margin Metrics
OPERATING MARGIN
19.94%
OPERATING MARGIN AVG TTM
17.74%
OPERATING MARGIN AVG 3Y
16.96%
OPERATING MARGIN AVG 5Y
16.56%
OPERATING MARGIN AVG 10Y
15.89%
OPERATING MARGIN AVG 15Y
15.01%
OPERATING MARGIN AVG 20Y
14.17%
CURRENT VS TTM AVG
+12.43%
CURRENT VS 3Y AVG
+17.59%
CURRENT VS 5Y AVG
+20.42%
CURRENT VS 10Y AVG
+25.50%
CURRENT VS 15Y AVG
+32.89%
CURRENT VS 20Y AVG
+40.76%
STE Competitors' Operating Margin
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| STERIS plc (STE) | $20.52B | 19.94% | 17.74% | 16.96% | 16.56% |
| Incyte Corporation (INCY)vs › | $21.48B | 27.05% | 14.26% | 15.92% | 12.23% |
| Labcorp Holdings Inc. (LH)vs › | $21.83B | 11.03% | 9.61% | 9.32% | 13.00% |
| Viatris Inc. (VTRS)vs › | $18.71B | 0.96% | -9.28% | -0.91% | -0.93% |
| BioNTech SE (BNTX)vs › | $22.76B | -51.55% | -35.20% | 5.18% | 14.03% |
| Quest Diagnostics Incorporated (DGX)vs › | $22.83B | 14.31% | 14.08% | 14.06% | 16.54% |
| United Therapeutics Corporation (UTHR)vs › | $23.34B | 45.34% | 47.77% | 49.26% | 45.01% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $17.60B | 15.61% | 16.64% | 15.15% | 12.43% |
| Moderna, Inc. (MRNA)vs › | $23.71B | -153.35% | -140.72% | -73.36% | -52.24% |
| Hologic, Inc. (HOLX)vs › | $16.97B | 17.49% | 19.66% | 22.41% | 27.16% |
Operating Efficiency
Gross Margin
44.3%
Operating Margin
19.9%
Operating Margin Formula & Definition
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Operating Margin FAQ
- What is the operating margin for STERIS plc (STE)?
- The operating margin for STE stock is 19.94%.
- Is STERIS plc's operating margin high or low?
- The operating margin of 19.94% is 49% above its 5-year average of 13.41%, near the high end of its 5-year range (-25.52%–21.97%).
- What is the TTM average operating margin for STERIS plc (STE)?
- The TTM average operating margin for STE stock is 17.74%.
- What is the 3Y average operating margin for STERIS plc (STE)?
- The 3Y average operating margin for STE stock is 16.96%.
- What is the 5Y average operating margin for STERIS plc (STE)?
- The 5Y average operating margin for STE stock is 16.56%.
- What is the 10Y average operating margin for STERIS plc (STE)?
- The 10Y average operating margin for STE stock is 15.89%.
- What is the 15Y average operating margin for STERIS plc (STE)?
- The 15Y average operating margin for STE stock is 15.01%.
- What is the 20Y average operating margin for STERIS plc (STE)?
- The 20Y average operating margin for STE stock is 14.17%.
STE Operating Margin History
| DATE | OPERATING MARGIN |
|---|---|
| 2026-03-31 | 19.94% |
| 2025-12-31 | 18.11% |
| 2025-09-30 | 18.35% |
| 2025-06-30 | 17.68% |
| 2025-03-31 | 14.60% |
| 2024-12-31 | 17.90% |
| 2024-09-30 | 16.53% |
| 2024-06-30 | 14.50% |
| 2024-03-31 | 21.97% |
| 2023-12-31 | 17.45% |
| 2023-09-30 | 15.47% |
| 2023-06-30 | 16.71% |
| 2023-03-31 | 16.28% |
| 2022-12-31 | 15.69% |
| 2022-09-30 | -25.52% |
| 2022-06-30 | 13.70% |
| 2022-03-31 | 7.59% |
| 2021-12-31 | 16.79% |
| 2021-09-30 | 9.73% |
| 2021-06-30 | 1.48% |
| 2021-03-31 | 16.72% |
| 2020-12-31 | 18.18% |
| 2020-09-30 | 18.68% |
| 2020-06-30 | 17.31% |
| 2020-03-31 | 19.17% |
| 2019-12-31 | 18.39% |
| 2019-09-30 | 17.20% |
| 2019-06-30 | 15.80% |
| 2019-03-31 | 18.34% |
| 2018-12-31 | 9.99% |
| 2018-09-30 | 15.70% |
| 2018-06-30 | 14.78% |
| 2018-03-31 | 15.87% |
| 2017-12-31 | 15.60% |
| 2017-09-30 | 15.54% |
| 2017-06-30 | 14.04% |
| 2017-03-31 | 8.61% |
| 2016-12-31 | 4.00% |
| 2016-09-30 | 10.76% |
| 2016-06-30 | 11.52% |
| 2016-03-31 | 14.39% |
| 2015-12-31 | 7.55% |
| 2015-09-30 | 4.63% |
| 2015-06-30 | 10.05% |
| 2015-03-31 | 13.61% |
| 2014-12-31 | 12.96% |
| 2014-09-30 | 11.55% |
| 2014-06-30 | 10.70% |
| 2014-03-31 | 12.81% |
| 2013-12-31 | 13.78% |
| 2013-09-30 | 13.11% |
| 2013-06-30 | 11.16% |
| 2013-03-31 | 15.20% |
| 2012-12-31 | 17.65% |
| 2012-09-30 | 17.48% |
| 2012-06-30 | 14.33% |
| 2012-03-31 | 18.97% |
| 2011-12-31 | 15.12% |
| 2011-09-30 | 13.90% |
| 2011-06-30 | 14.72% |
| 2011-03-31 | 15.21% |
| 2010-12-31 | 10.91% |
| 2010-09-30 | 17.57% |
| 2010-06-30 | -33.34% |
| 2010-03-31 | 15.46% |
| 2009-12-31 | 18.13% |
| 2009-09-30 | 15.93% |
| 2009-06-30 | 15.12% |
| 2009-03-31 | 13.83% |
| 2008-12-31 | 14.34% |
| 2008-09-30 | 14.54% |
| 2008-06-30 | 11.25% |
| 2008-03-31 | 11.21% |
| 2007-12-31 | 10.66% |
| 2007-09-30 | 8.97% |
| 2007-06-30 | 7.68% |
| 2007-03-31 | 14.82% |
| 2006-12-31 | 11.32% |
| 2006-09-30 | 32.53% |
| 2006-06-30 | 9.61% |
| 2006-03-31 | 5.62% |
| 2005-12-31 | 13.58% |
| 2005-09-30 | 32.09% |
| 2005-06-30 | 9.92% |
| 2005-03-31 | 14.63% |
| 2004-12-31 | 14.09% |
| 2004-09-30 | 11.65% |
| 2004-06-30 | 11.00% |
| 2004-03-31 | 14.86% |
| 2003-12-31 | 13.79% |
| 2003-09-30 | 12.56% |
| 2003-06-30 | 10.11% |
| 2003-03-31 | 15.33% |
| 2002-12-31 | 13.93% |
| 2002-09-30 | 12.54% |
| 2002-06-30 | 9.30% |
About STERIS plc
STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Daniel A. Carestio